FDA Issues Drug Safety Communication Regarding Use of General Anesthetic and Sedation Drugs in Young Children

Medical Drug Safety

Today, the FDA issued a drug safety communication that it has approved previously announced label changes regarding the use of general anesthetic and sedation medicines in children younger than 3 years. These changes include: A new Warning stating that exposure to these medicines for lengthy periods of time or over multiple surgeries or procedures may…

Read More

Eliquis Blood Thinner Medication Lawsuits for Life-Threatening & Irreversible Bleeds – Litigation Update

Blood Thinner Litigation

Lawsuits have been and continue to be filed by individuals who have suffered various bleed-related injuries (often irreversible and fatal) as a result of taking Eliquis (apixaban), an oral tablet used to reduce the risk of stroke and dangerous blood clots (systemic embolism). Eliquis is manufactured by Bristol-Myers Squibb Company of Princeton, N.J. and marketed…

Read More